Several pivotal metabolites within the glycolysis pathway are markedly diminished in esophageal cancer tissues with high ILF3 expression, leading to metabolic reprogramming and promoting esophageal cancer progression [17]. This evidence concerns the gene ILF3 and esophageal cancer.